Nordic Life Science 1
ADVERTOR I AL Customized services in preclinical
development Redoxis is a CRO with core expertise and focus on preclinical drug development and efficacy evaluation in models of inflammatory and autoimmune disease. WITH THE ROOTS in academic research we strive to be aligned with the latest immunology research and are continuously updating our portfolio of models. With a dedicated team and a fully equipped laboratory, we are performing preclinical in vivo and in vitro models, including in vivo efficacy evaluation, functional assays, mechanism of action (MoA) studies, ex vivo ranking, pharmacokinetic (PK) investigation, and biomarker analyses. What makes us unique is our flexibility in study design to accommodate each project. With a project specific design, we provide reliable results that bring value to our customers’ preclinical programs. With a flexible study design and broad competence and knowledge base within the field of inflammatory and immunity, we aim to work closely together with our partners and act as a prolongation of their own team of researchers. Whatever your needs, our Pharma Services have you covered. From the development to the production of your oral solid dosage form (OSD) our Pharma Services assist you along the full drug product lifecycle. Syntegon has four fully equipped OSD Customer Centers in the U.S, Germany and China, as well as a global network of partner labs. Bridging the gap between drug development and production . syntegon.com Syntegon_Ad_LifeSiences_200x126_GapDrugDevelopment_02_2022.indd 1 26.01.2023 08:12:59 Our focus on quality and efficiency will help you to reach the full potential with regards to competitiveness and sustainability of your product – from mixing, granulating, drying, tablet pressing and coating, pellets manufacturing and capsule filling.